Schrodinger's three largest insider shareholders as of June 06, 2026 are David E Shaw (TenPercentOwner, 6.10Mn shares), Richard Friesner (Director, 682.22K shares), Ramy Farid (President Ceo, 405.35K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| David E Shaw | - | 0 | 6,103,042 | 19 Jul, 2021 |
| Gary L Ginsberg | - | 17,247 | 0 | 20 Jun, 2025 |
| Arun Oberoi | - | 17,247 | 0 | 20 Jun, 2025 |
| Kralingen Bridget A Van | - | 11,499 | 0 | 20 Jun, 2025 |
| Michael Lynton | - | 17,247 | 0 | 20 Jun, 2025 |
| Jeffrey Chodakewitz | - | 17,247 | 0 | 20 Jun, 2025 |
| Gary Sender | - | 17,247 | 0 | 20 Jun, 2025 |
| Karen Akinsanya | President Of Rd, Therapeutics | 69,956 | 0 | 06 Mar, 2026 |
| Ramy Farid | President Ceo | 405,351 | 0 | 17 Apr, 2026 |
| Kenneth Patrick Lorton | Evp, Cto Coo, Software | 89,241 | 0 | 06 Mar, 2026 |
| Yvonne Tran | Evp, Clo Cpo | 52,683 | 0 | 06 Mar, 2026 |
| Jenny Herman | Cao | 34,804 | 0 | 06 Mar, 2026 |
| Rosana Kapeller-Libermann | - | 17,247 | 0 | 20 Jun, 2025 |
| Robert Lorne Abel | Evp, Science | 55,897 | 0 | 06 Mar, 2026 |
| Richard Friesner | - | 682,224 | 0 | 03 Mar, 2026 |
| Margaret Dugan | Chief Medical Officer | 24,574 | 0 | 17 Oct, 2025 |
| Geoffrey Craig Porges | Evp Cfo | 27,544 | 0 | 04 Mar, 2025 |
| Mannix Vartan Aklian | - | 31,193 | 0 | 03 Mar, 2026 |
| Rachit Jain | Evp Cfo | 52,596 | 0 | 06 Mar, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 16 Apr, 2026 | Ramy Farid | Common Stock | A | 43,000 | $3.07 | 373,824 | D | M |
| 16 Apr, 2026 | Ramy Farid | Common Stock | D | 43,000 | $12.33 | 330,824 | D | S |
| 17 Apr, 2026 | Ramy Farid | Common Stock | A | 43,000 | $3.07 | 373,824 | D | M |
| 17 Apr, 2026 | Ramy Farid | Common Stock | D | 43,000 | $12.21 | 330,824 | D | S |
| 17 Apr, 2026 | Ramy Farid | Common Stock | A | 74,527 | $3.07 | 405,351 | D | M |
| 16 Apr, 2026 | Ramy Farid | Stock Option (right to buy) | D | 43,000 | $0.00 | 117,527 | D | M |
| 17 Apr, 2026 | Ramy Farid | Stock Option (right to buy) | D | 43,000 | $0.00 | 74,527 | D | M |
| 17 Apr, 2026 | Ramy Farid | Stock Option (right to buy) | D | 74,527 | $0.00 | 0 | D | M |
| 05 Mar, 2026 | Rachit Jain | Common Stock | D | 1,631 | $12.90 | 52,596 | D | S |
| 05 Mar, 2026 | Ramy Farid | Common Stock | D | 3,661 | $12.91 | 330,824 | D | S |
| 05 Mar, 2026 | Karen Akinsanya | Common Stock | D | 1,366 | $12.90 | 69,956 | D | S |
| 05 Mar, 2026 | Yvonne Tran | Common Stock | D | 1,094 | $12.90 | 52,683 | D | S |
| 05 Mar, 2026 | Kenneth Patrick Lorton | Common Stock | D | 1,222 | $12.90 | 89,241 | D | S |
| 05 Mar, 2026 | Yvonne Tran | Common Stock | D | 1,094 | $12.90 | 52,683 | D | S |
| 05 Mar, 2026 | Yvonne Tran | Common Stock | D | 1,094 | $12.90 | 52,683 | D | S |
| 04 Mar, 2026 | Robert Lorne Abel | Common Stock | D | 1,300 | $12.81 | 55,897 | D | S |
| 05 Mar, 2026 | Jenny Herman | Common Stock | D | 775 | $12.85 | 35,412 | D | S |
| 06 Mar, 2026 | Jenny Herman | Common Stock | D | 608 | $12.84 | 34,804 | D | S |
| 02 Mar, 2026 | Yvonne Tran | Common Stock | A | 17,130 | $0.00 | 39,989 | D | A |
| 02 Mar, 2026 | Yvonne Tran | Common Stock | A | 17,130 | $0.00 | 39,989 | D | A |